ADVERTISEMENT

Dolutegravir Resistance Rare, but Testing Recommended

Liz Scherer   |   Clinical Summary   |   03 November 2023
ADVERTISEMENT

Key finding

Resistance to dolutegravir among people living with HIV-1 infection is currently rare but not negligible, especially when it occurs concurrently with nucleotide reverse transcriptase inhibitors (NRTIs) resistance. This global study was conducted by Swiss, German, French, English, and South African researchers and appeared online in the journal Lancet ...

          

November Challenge

Ends in 1d 12h
left
right

Topic Challenges

left
right